in Health care
Dr Reddys Labs unveils Treprostinil Injection in US
Hyderabad: Dr. Reddy’s Laboratories Ltd. has announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA). Treprostinil injection is a prostacyclin mimetic indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated […] More
